- Home
- PMVP vs NTRB Comparison
PMVP vs NTRB Comparison
Compare PMVP & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- NTRB
- Stock Information
- Founded
- PMVP 2013
- NTRB 2016
- Country
- PMVP United States
- NTRB United States
- Employees
- PMVP N/A
- NTRB N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- NTRB Industrial Specialties
- Sector
- PMVP Health Care
- NTRB Health Care
- Exchange
- PMVP Nasdaq
- NTRB Nasdaq
- Market Cap
- PMVP 85.5M
- NTRB 77.9M
- IPO Year
- PMVP 2020
- NTRB N/A
- Fundamental
- Price
- PMVP $1.65
- NTRB $6.17
- Analyst Decision
- PMVP Strong Buy
- NTRB
- Analyst Count
- PMVP 4
- NTRB 0
- Target Price
- PMVP $5.75
- NTRB N/A
- AVG Volume (30 Days)
- PMVP 185.0K
- NTRB 28.2K
- Earning Date
- PMVP 11-07-2024
- NTRB 12-11-2024
- Dividend Yield
- PMVP N/A
- NTRB N/A
- EPS Growth
- PMVP N/A
- NTRB N/A
- EPS
- PMVP N/A
- NTRB N/A
- Revenue
- PMVP N/A
- NTRB $1,803,816.00
- Revenue This Year
- PMVP N/A
- NTRB N/A
- Revenue Next Year
- PMVP N/A
- NTRB N/A
- P/E Ratio
- PMVP N/A
- NTRB N/A
- Revenue Growth
- PMVP N/A
- NTRB N/A
- 52 Week Low
- PMVP $1.33
- NTRB $1.93
- 52 Week High
- PMVP $3.47
- NTRB $9.60
- Technical
- Relative Strength Index (RSI)
- PMVP 60.86
- NTRB 50.57
- Support Level
- PMVP $1.63
- NTRB $5.24
- Resistance Level
- PMVP $1.69
- NTRB $6.40
- Average True Range (ATR)
- PMVP 0.07
- NTRB 0.71
- MACD
- PMVP 0.01
- NTRB -0.12
- Stochastic Oscillator
- PMVP 52.65
- NTRB 33.23
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.